Derikx Joep P M, Poeze Martijn, van Bijnen Annemarie A, Buurman Wim A, Heineman Erik
Department of Surgery, University Hospital Maastricht & Nutrition and Toxicology Research Institute (NUTRIM), Maastricht University, Maastricht, The Netherlands.
Shock. 2007 Nov;28(5):544-8. doi: 10.1097/shk.0b013e3180644e32.
The development of sepsis and multiple organ failure are important determinants of the outcome in critically ill patients. Hepatosplanchnic hypoperfusion and resulting intestinal and hepatic cell damage have been implicated as central events in the development of sepsis and multiple organ failure. Our aim was to study (1) the relation between intramucosal perfusion and intestinal and hepatic cell damage in an early phase of sepsis and (2) the correlation of these parameters with mortality. Two groups of patients were consecutively selected after intensive care unit admission: patients with postoperative abdominal sepsis (n = 19) and patients with pneumonia-induced sepsis (n = 9). Intramucosal perfusion was assessed by gastric tonometry (Pr-aCO2 gap, Pico2). Circulating levels of intestinal fatty acid binding protein (I-FABP) and liver (L)-FABP were used as markers for intestinal and hepatic cellular damage, respectively. Outcome was determined on day 28. Pr-aCO2 gap correlated with I-FABP (Pearson r = 0.56; P < 0.001) in all patients, and gastric mucosal Pico2 correlated significantly with I-FABP (r = 0.57; P = 0.001) in patients with abdominal sepsis. At intensive care unit admission, nonsurvivors had significantly higher I-FABP and L-FABP values than survivors (I-FABP: 325 vs. 76 pg/mL, P < 0.04; L-FABP: 104 vs. 31 ng/mL, P < 0.04). Patients with abdominal sepsis was especially responsible for high-admission I-FABP and L-FABP levels in nonsurvivors (I-FABP: 405 vs. 85 pg/mL, P < 0.04; L-FABP: 121 vs. 59 ng/mL, P < 0.04). This study shows that splanchnic hypoperfusion correlates with intestinal mucosal damage, and that elevated plasma levels of I-FABP and L-FABP are associated with a poor outcome in critically ill patients with abdominal sepsis.
脓毒症和多器官功能衰竭的发生是重症患者预后的重要决定因素。肝脾低灌注以及由此导致的肠和肝细胞损伤被认为是脓毒症和多器官功能衰竭发生过程中的核心事件。我们的目的是研究:(1)脓毒症早期黏膜内灌注与肠和肝细胞损伤之间的关系;(2)这些参数与死亡率的相关性。在重症监护病房收治患者后连续选取两组患者:术后腹部脓毒症患者(n = 19)和肺炎所致脓毒症患者(n = 9)。通过胃张力测定法(Pr-aCO2差值、Pico2)评估黏膜内灌注。肠道脂肪酸结合蛋白(I-FABP)和肝脏(L)-FABP的循环水平分别用作肠和肝细胞损伤的标志物。在第28天确定预后。在所有患者中,Pr-aCO2差值与I-FABP相关(Pearson相关系数r = 0.56;P < 0.001),在腹部脓毒症患者中,胃黏膜Pico2与I-FABP显著相关(r = 0.57;P = 0.001)。在重症监护病房收治时,非存活者的I-FABP和L-FABP值显著高于存活者(I-FABP:325 vs. 76 pg/mL,P < 0.04;L-FABP:104 vs. 31 ng/mL,P < 0.04)。腹部脓毒症患者对非存活者入院时较高的I-FABP和L-FABP水平尤其起了作用(I-FABP:405 vs. 85 pg/mL,P < 0.04;L-FABP:121 vs. 59 ng/mL,P < 0.04)。本研究表明,内脏低灌注与肠黏膜损伤相关,并且在患有腹部脓毒症的重症患者中,血浆I-FABP和L-FABP水平升高与不良预后相关。